P

Inventor

ZHANG HONGJIE

HK45 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG HONGJIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV HONG KONG BAPTIST UNIV

18 patents
US9822071B2Nov 21, 2017

Anticancer miliusane lactams

UNIV HONG KONG BAPTIST UNIV2 citations73
US9956152B2May 1, 2018

Skin-protection composition containing dendrobium-based ingredients

UNIV HONG KONG BAPTIST UNIV2 citations72
US9562059B2Feb 7, 2017

Anticancer maytansinoids with two fused macrocyclic rings

UNIV HONG KONG BAPTIST UNIV2 citations64
US9738581B2Aug 22, 2017

Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions

UNIV HONG KONG BAPTIST UNIV1 citations58
US12337007B2Jun 24, 2025

Patentiflorin A analogs as antiviral agents

UNIV HONG KONG BAPTIST UNIV0 citations54
US11638713B2May 2, 2023

Patentiflorin A analogs as antiviral agents

UNIV HONG KONG BAPTIST UNIV1 citations54
US10188590B2Jan 29, 2019

Skin-protection composition containing Dendrobium-based ingredients

UNIV HONG KONG BAPTIST UNIV0 citations51
US10017442B2Jul 10, 2018

Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies

UNIV HONG KONG BAPTIST UNIV0 citations51
US9526706B1Dec 27, 2016

Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury

UNIV HONG KONG BAPTIST UNIV0 citations51
US9877931B2Jan 30, 2018

Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions

UNIV HONG KONG BAPTIST UNIV0 citations48
US10493056B2Dec 3, 2019

Method of use of diterpenoid derivatives as anticancer agents

UNIV HONG KONG BAPTIST UNIV0 citations46
US9795589B1Oct 24, 2017

Method of use of diterpenoid derivatives as anticancer agents

UNIV HONG KONG BAPTIST UNIV1 citations46
US9540299B2Jan 10, 2017

MTOR-independent activator of TFEB for autophagy enhancement and uses thereof

UNIV HONG KONG BAPTIST UNIV0 citations44
US10323012B2Jun 18, 2019

Miliusanes as antiviral agents

UNIV HONG KONG BAPTIST UNIV0 citations42
US9963485B2May 8, 2018

Cycloheptapeptide agents for treatment of cancer and obesity diseases

UNIV HONG KONG BAPTIST UNIV0 citations42
US9499586B2Nov 22, 2016

Anticancer and anti-obesity cyclic peptide agents

UNIV HONG KONG BAPTIST UNIV0 citations42
US10351500B2Jul 16, 2019

Method of using of dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants as antimicrobial agents

UNIV HONG KONG BAPTIST UNIV0 citations40
US9695141B2Jul 4, 2017

Anticancer miliusane derivatives

UNIV HONG KONG BAPTIST UNIV0 citations31

CHANGCHUN INST APPLIED CHEMISTRY CAS

5 patents

XIANGSHUI YUCHEN HORTICULTURAL PRODUCTS CO LTD

4 patents

UNIV HONG KONG BAPTIST

2 patents

ZHANG HONGJIE

2 patents

SICHUAN SUN FOR LIGHT CO LTD

2 patents

CHANGCHUN APPLIED CHEMISTRY

2 patents

DALIAN INST CHEM & PHYSICS CAS

2 patents

JIANGSU MINGMA BIOTECH CO LTD

2 patents

BEIPU MEDICAL TECH CO LTD

1 patent

COMMERCIAL AIRCRAFT CORP CN

1 patent

CHEN QI

1 patent

SICHUAN SUNFOR LIGHT CO LTD

1 patent

BAOTOU RARE EARTH RES AND DEVELOPMENT CENTER CHINESE ACADEMY OF SCIENCES

1 patent

BERPU MEDICAL TECH CO LTD

1 patent